Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan

Pharmaceuticals(2023)10.3390/ph16101498Source: DataRank Database

Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan is a research paper published in Pharmaceuticals (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: goldTopics (17)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Srinivas Ayyadevara ORCID,Nirjal Mainali ORCID,Meenakshisundaram Balasubramaniam ORCID,B. Suresh Kuarm ORCID,Narsimha Reddy Penthala ORCID

Live enrichment

PubMed:37895969 PMC:PMC10610358

VA Merit Award

Grant: 2 I01 BX001655

BLRD VA

Grant: IK6 BX004851

National Institute on Aging

Grant: 2P01AG012411-17A1

Early Events in Alzheimer Pathogenesis

National Institute on Aging

Grant: 1R01AG084473

NIA NIH HHS

Grant: P01 AG012411

NIA NIH HHS

Grant: R01 AG084473

BLRD VA

Grant: I01 BX001655

National Institutes of Health

Grant: 1R01AG084473-01

Role of glucose transport in Alzheimer's disease pathogenesis

Inglewood Scholars Program

Windgate Foundation and the Philip R. Jonsson Foundation

goldLicense: cc-by

publisherhttps://www.mdpi.com/1424-8247/16/10/1498/pdf?version=1697817234

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10610358/pdf/pharmaceuticals-16-01498.pdf

repositoryhttps://doaj.org/article/5ef6117e54514590994189c991ada0a2

Europe_PMChttps://europepmc.org/articles/PMC10610358

Europe_PMChttps://europepmc.org/articles/PMC10610358?pdf=render

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Molecular modelingAggregationNeurodegenerative diseaseProtein aggregationNeurodegenerationAlzheimer’s diseaseProteostasisGlycogen Synthase Kinase 3Β (Gsk3β)Thiadiazolidinones (Tdzds)RArticleRS1-441Pharmacy and materia medicaMedicine

Sustainable Development Goals

SDG 3: 3. Good health